These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25841891)

  • 1. Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial.
    Baqui AH; Saha SK; Ahmed AS; Shahidullah M; Quasem I; Roth DE; Samsuzzaman AK; Ahmed W; Tabib SM; Mitra DK; Begum N; Islam M; Mahmud A; Rahman MH; Moin MI; Mullany LC; Cousens S; El Arifeen S; Wall S; Brandes N; Santosham M; Black RE;
    Lancet Glob Health; 2015 May; 3(5):e279-87. PubMed ID: 25841891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1767-1776. PubMed ID: 25842221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1758-1766. PubMed ID: 25842223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial.
    Mir F; Nisar I; Tikmani SS; Baloch B; Shakoor S; Jehan F; Ahmed I; Cousens S; Zaidi AK
    Lancet Glob Health; 2017 Feb; 5(2):e177-e185. PubMed ID: 27988146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral amoxicillin plus gentamicin regimens may be superior to the procaine-penicillin plus gentamicin regimens for treatment of young infants with possible serious bacterial infection when referral is not feasible: Pooled analysis from three trials in Africa and Asia.
    Longombe AL; Ayede AI; Marete I; Mir F; Ejembi CL; Shahidullah M; Adejuyigbe EA; Wammanda RD; Tshefu A; Esamai F; Zaidi AK; Baqui AH; Cousens S
    J Glob Health; 2022 Nov; 12():04084. PubMed ID: 36403158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of simplified antibiotic regimens for outpatient treatment of serious infection in neonates and young infants 0-59 days of age in Bangladesh: design of a randomized controlled trial.
    Baqui AH; Saha SK; Ahmed AS; Shahidullah M; Quasem I; Roth DE; Williams EK; Mitra D; Shamsuzzaman AK; Ahmed W; Mullany LC; Cousens S; Wall S; Brandes N; Black RE
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S12-8. PubMed ID: 23945570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.
    Duby J; Lassi ZS; Bhutta ZA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD007646. PubMed ID: 30970390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa.
    Garg CC; Tshefu A; Longombe AL; Kila JN; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Hyellashelni JD; Yoshida S; Gram L; Nisar YB; Qazi SA; Bahl R
    PLoS One; 2021; 16(3):e0247977. PubMed ID: 33720960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial.
    Zaidi AK; Tikmani SS; Sultana S; Baloch B; Kazi M; Rehman H; Karimi K; Jehan F; Ahmed I; Cousens S
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S19-25. PubMed ID: 23945571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens.
    Zaidi AK; Tikmani SS; Warraich HJ; Darmstadt GL; Bhutta ZA; Sultana S; Thaver D
    Pediatr Infect Dis J; 2012 Jul; 31(7):667-72. PubMed ID: 22481421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How long should young infants less than two months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalised for? Study protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04056. PubMed ID: 37448340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal place of treatment for young infants aged less than two months with any low-mortality-risk sign of possible serious bacterial infection: Study Protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04055. PubMed ID: 37449353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial.
    AFRIcan NEonatal Sepsis Trial Group
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S33-8. PubMed ID: 23945574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research.
    Leul A; Hailu T; Abraham L; Bayray A; Terefe W; Godefay H; Fantaye M; Qazi SA; Aboubaker S; Nisar YB; Bahl R; Tekle E; Mulugeta A
    PLoS One; 2021; 16(2):e0244192. PubMed ID: 33544712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified antibiotic regimens for treating neonates and young infants with severe infections in the Democratic Republic of Congo: a comparative efficacy trial.
    Lokangaka A; Bauserman M; Coppieters Y; Engmann C; Qazi S; Tshefu A; Bose C
    Matern Health Neonatol Perinatol; 2018; 4():8. PubMed ID: 29713491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
    Hill LF; Clements MN; Turner MA; Donà D; Lutsar I; Jacqz-Aigrain E; Heath PT; Roilides E; Rawcliffe L; Alonso-Diaz C; Baraldi E; Dotta A; Ilmoja ML; Mahaveer A; Metsvaht T; Mitsiakos G; Papaevangelou V; Sarafidis K; Walker AS; Sharland M;
    Lancet Child Adolesc Health; 2022 Jan; 6(1):49-59. PubMed ID: 34843669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
    Keij FM; Kornelisse RF; Hartwig NG; van der Sluijs-Bens J; van Beek RHT; van Driel A; van Rooij LGM; van Dalen-Vink I; Driessen GJA; Kenter S; von Lindern JS; Eijkemans M; Stam-Stigter GM; Qi H; van den Berg MM; Baartmans MGA; van der Meer-Kappelle LH; Meijssen CB; Norbruis OF; Heidema J; van Rossem MC; den Butter PCP; Allegaert K; Reiss IKM; Tramper-Stranders GA
    Lancet Child Adolesc Health; 2022 Nov; 6(11):799-809. PubMed ID: 36088952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.